Cargando…
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine
The mortality rate of the recent global pandemic corona virus disease 2019 (COVID-19) is currently as high as 7%. The SARS-CoV-2 virus is the culprit behind COVID-19. SARS-CoV-2 is an enveloped single-stranded RNA virus, the genome encodes four types of the structural proteins: S protein, E protein...
Autores principales: | Ling, Yuyan, Dong, Yuxuan, Li, Qirui, Huang, Doudou, Li, Zhihui, Chen, Meijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343068/ https://www.ncbi.nlm.nih.gov/pubmed/35937968 http://dx.doi.org/10.1016/j.medntd.2022.100159 |
Ejemplares similares
-
Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling
por: Payandeh, Zahra, et al.
Publicado: (2018) -
Quantitative Proteomic Analysis of Cellular Responses to a Designed Amino Acid Feed in a Monoclonal Antibody Producing Chinese Hamster Ovary Cell Line
por: Torkashvand, Fatemeh, et al.
Publicado: (2018) -
Traditional Chinese Medicine is effective for COVID-19: A systematic review and meta-analysis
por: Xu, Jiayi, et al.
Publicado: (2022) -
Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants
por: Pour, Mahdi Alikhani, et al.
Publicado: (2017) -
Constant domain polymorphisms influence monoclonal antibody stability and dynamics
por: Warrender, Annmaree K., et al.
Publicado: (2023)